Patients relying on the prescription drug Humira will face challenges as many Medicare Part D plans are set to drop its coverage starting January 2026. This decision affects numerous beneficiaries, including individuals like Gene from Sugar Land, Texas, who rely on the drug for managing Crohn’s disease.
Gene recently learned that his Medicare Part D plan would no longer cover Humira, a medication he administers bi-monthly. His existing supplemental Medicare Plan G and Part D prescription drug plan, which began in January 2021, had previously provided the necessary support. Despite researching options on the Medicare.gov website, Gene discovered that no available 2026 Part D plans would cover Humira.
The financial implications of this change are significant. According to the Medicare.gov website, the total cost for Humira will amount to approximately $99,691.68 annually, translating to about $8,307.64 per month. This steep price tag has raised concerns among patients who may now be forced to explore alternative medications or financial assistance options.
The drop in coverage for Humira appears to be linked to the introduction of similar, less expensive alternatives. As a result, Medicare Part D formularies are opting out of covering the brand-name drug. In light of these changes, Gene is advised to consult with his prescribing physician to discuss potential alternatives to Humira.
For further assistance, contacting AbbVie, the manufacturer of Humira, could be beneficial. Patients can reach out to their customer service line at 800-222-6885 to inquire about potential prescription drug assistance programs that may alleviate some of the financial burdens.
As the Medicare open enrollment period unfolds, it is crucial for the approximately 69 million Medicare beneficiaries to verify their prescription coverage. Whether enrolled in a stand-alone Medicare Part D plan or a Medicare Advantage plan that includes a prescription drug component, beneficiaries should ensure that their medications are covered.
Understanding Medicare Prescription Drug Costs
The financial landscape of Medicare prescription drug coverage is complex. For 2026, key costs include an initial deductible of $615. During the initial coverage stage, beneficiaries will pay their share of drug costs until reaching a maximum out-of-pocket amount of $2,100. After this threshold is met, beneficiaries enter the catastrophic coverage stage, where Medicare covers all costs for covered prescriptions, whether they are brand-name or generic.
Navigating these changes requires careful consideration and proactive measures. Beneficiaries should regularly review their coverage options and remain informed about their prescription needs to avoid unexpected financial strain. As the landscape of Medicare continues to evolve, understanding these details becomes essential for maintaining health and financial stability.
